T. Rowe Price Associates
DBD icon

T. Rowe Price Associates’s Diebold Nixdorf DBD Stock Holding History

T. Rowe Price Associates’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
27,139
+4,269
+19% +$314K ﹤0.01% 1813
2025
Q4 		$1.55M Sell
22,870
-586
-2% -$36.6K ﹤0.01% 1873
2025
Q3 		$1.34M Buy
23,456
+974
+4% +$57.7K ﹤0.01% 1931
2025
Q2 		$1.25M Buy
22,482
+1,266
+6% +$59.4K ﹤0.01% 1877
2025
Q1 		$928K Buy
21,216
+11,422
+117% +$498K ﹤0.01% 1996
2024
Q4 		$422K Buy
9,794
+1,459
+18% +$65.7K ﹤0.01% 2359
2024
Q3 		$373K Buy
+8,335
New +$345K ﹤0.01% 2378

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

T. Rowe Price Associates's DBD Position: Q1 2026 in Review

T. Rowe Price Associates increased its Diebold Nixdorf (DBD) stake by 19% in Q1 2026, buying an estimated $314K and bringing the position to 27,139 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

T. Rowe Price Associates first reported a position in DBD in Q3 2024 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • T. Rowe Price Associates held 27,139 shares of Diebold Nixdorf worth $2.05M as of Q1 2026.
  • T. Rowe Price Associates bought 4,269 Diebold Nixdorf shares in Q1 2026, an estimated $314K.
  • Diebold Nixdorf made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1813 holding.
  • T. Rowe Price Associates first reported a position in Diebold Nixdorf in Q3 2024 and has held it in 7 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.